Literature DB >> 7898143

Spontaneous bacterial peritonitis: an update.

J A Gilbert1, P S Kamath.   

Abstract

OBJECTIVE: To describe spontaneous bacterial peritonitis (SBP) in the context of currently accepted criteria for diagnosis, treatment, and prevention.
DESIGN: A review of SBP and its associated etiopathogenic factors is presented.
MATERIAL AND METHODS: Numerous studies on mechanisms of disease, diagnosis, treatment, and prevention are discussed. Diagnostic and therapeutic algorithms are presented.
RESULTS: Peritonitis in patients with ascites in the absence of secondary causes, such as peforation of a viscus, occurs primarily in patients with end-stage liver disease. Enteric organisms, mainly gram-negative bacilli, probably translocate to regional lymph nodes to produce bacteremia and seeding of ascitic fluid. Signs and symptoms of peritonitis are usually subtle. The ascitic fluid polymorphonuclear leukocyte count is the best determinant for early diagnosis and treatment of SBP. Third-generation cephalosporins such as cefotaxime are considered the drugs of choice for treatment, whereas quinolones such as norfloxacin are used to decrease recurrence.
CONCLUSION: Despite increased awareness, early diagnosis, and prompt and effective antimicrobial therapy, SBP recurs frequently and is associated with a high mortality rate. Patients with SBP should be assessed for candidacy for liver transplantation.

Entities:  

Mesh:

Year:  1995        PMID: 7898143     DOI: 10.4065/70.4.365

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  10 in total

1.  Accuracy of the automated cell counters for management of spontaneous bacterial peritonitis.

Authors:  Oliviero Riggio; Stefania Angeloni; Antonella Parente; Cinzia Leboffe; Giorgio Pinto; Teresa Aronne; Manuela Merli
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

2.  Ascitic fluid analysis for diagnosis and monitoring of spontaneous bacterial peritonitis.

Authors:  Oliviero Riggio; Stefania Angeloni
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

3.  Bacterial translocation in chronic portal hypertensive and common bile duct-ligated growing rats.

Authors:  G Schimpl; P Pesendorfer; G Steinwender; G Feierl; M Ratschek; M E Höllwarth
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

4.  Allopurinol and glutamine attenuate bacterial translocation in chronic portal hypertensive and common bile duct ligated growing rats.

Authors:  G Schimpl; P Pesendorfer; G Steinwender; G Feierl; M Ratschek; M E Höllwarth
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

5.  The role of nuclear factor-kappa B in bacterial translocation in cholestatic rats.

Authors:  D Weber-Mzell; P Zaupa; T Petnehazy; H Kobayashi; G Schimpl; G Feierl; P Kotanko; M Höllwarth
Journal:  Pediatr Surg Int       Date:  2006-01       Impact factor: 1.827

6.  Intraperitoneal microdialysis as a monitoring method in the intensive care unit.

Authors:  Tasiopoulos Konstantinos; Komnos Apostolos; Paraforos Georgios; Tepetes Konstantinos
Journal:  Int Surg       Date:  2014 Nov-Dec

7.  A tungsten supplemented diet attenuates bacterial translocation in chronic portal hypertensive and cholestatic rats: role of xanthine dehydrogenase and xanthine oxidase.

Authors:  G Schimpl; M A Pabst; G Feierl; A Kuesz; H Ozbey; S Takahashi; M E Höllwarth
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

8.  Granulocyte colony-stimulating factor improves deficient in vitro neutrophil transendothelial migration in patients with advanced liver disease.

Authors:  Carmen Fiuza; Magdalena Salcedo; Gerardo Clemente; Jose M Tellado
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

Review 9.  [Spontaneous bacterial peritonitis].

Authors:  J Zundler; J C Bode
Journal:  Med Klin (Munich)       Date:  1998-10-15

10.  Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice.

Authors:  Stefania Angeloni; Cinzia Leboffe; Antonella Parente; Mario Venditti; Alessandra Giordano; Manuela Merli; Oliviero Riggio
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.